PAPPAS CAPITAL
Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. They operate three lines of business: Pappas Ventures, their flagship venture arm; Specialized Fund Management, where we create and manage custom-tailored investment vehicles; and Translational Medicine, where we partner with research universities to accelerate the development of their scientific discoveries and inventions.
PAPPAS CAPITAL
Industry:
Biotechnology Delivery Medical Device Pharmaceutical
Founded:
1994-01-01
Status:
Active
Contact:
919-998-3300
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag
Current Advisors List
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | Aktis Oncology | Pappas Capital investment in Series A - Aktis Oncology | 84 M USD |
| 2022-06-02 | Yueer Gene | Pappas Capital investment in Series B - Yueer Gene | 50 M USD |
| 2022-06-02 | NuProbe | Pappas Capital investment in Series B - NuProbe | 50 M USD |
| 2022-04-14 | Us2.ai | Pappas Capital investment in Series A - Us2.ai | 15 M USD |
| 2022-02-23 | Plexium | Pappas Capital investment in Series B - Plexium | 102 M USD |
| 2022-01-05 | AvengeBio | Pappas Capital investment in Series A - AvengeBio | 45 M USD |
| 2021-09-29 | BioAtla | Pappas Capital investment in Post-IPO Equity - BioAtla | 75 M USD |
| 2020-12-09 | Reneo Pharmaceuticals | Pappas Capital investment in Series B - Reneo Pharmaceuticals | 95 M USD |
| 2020-07-31 | Cyclerion Therapeutics | Pappas Capital investment in Post-IPO Equity - Cyclerion Therapeutics | 24 M USD |
| 2020-07-15 | BioAtla | Pappas Capital investment in Series D - BioAtla | 72.5 M USD |